Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunityHuiming Chen, Shu‐Hsia Chen|Journal of Clinical Investigation|2018Cited by 262
A visual–omics foundation model to bridge histopathology with spatial transcriptomicsWeiqing Chen, Guangyu Wang, Pengzhi Zhang et al.|Nature Methods|2025Cited by 76
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removalXiaoxin Hao, Xiang H.-F. Zhang, Luis Becerra Dominguez et al.|Cell stem cell|2023Cited by 59
Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer preventionQi Zhang, Ming You, Jing Pan et al.|Frontiers in Immunology|2023Cited by 21
LILRB3 genetic variation is associated with kidney transplant failure in African American recipientsZeguo Sun, Zhengzi Yi, Chengguo Wei et al.|Nature Medicine|2025Cited by 8